Wikipedia

Rodney Sinclair

Rodney Sinclair is an Australian dermatologist and scientific researcher specializing in the study and treatment of alopecia (hair loss) and inflammatory skin diseases.[1][2][3] His affiliations include the University of Melbourne, St. Vincent's Hospital, Epworth Hospital, and the Sinclair Dermatology Institute for Research, among others.[1][2][3][4] He is responsible for the Sinclair scale hair loss grading system.[1] In addition, Sinclair was responsible for the emergence of low-dose oral minoxidil (LDOM) for treatment of hair loss starting in 2015 with his publications in this area.[5][4][2][6][7][8][9] He is also the founder and director of Samson Clinical, which is developing sublingual minoxidil (SLM) for hair loss.[10][11][12] Sinclair has written 7 textbooks in the area of dermatology and published more than 500 research articles.[1][3]

Rodney Sinclair
Other namesRodney D. Sinclair; Rodney Daniel Sinclair
OccupationsDermatologist, scientific researcher
Known forHair loss research, low-dose oral minoxidil, sublingual minoxidil
Websitewww.sinclairdermatology.com.au/team/prof-rod-sinclair/

References

edit
  1. 1 2 3 4 Farjo, Nilofer; Sinclair, Rod; Rufaut, Nick (2009). "Hair Sciences: An interview with Dr. Rodney Sinclair on female pattern hair loss". International Society of Hair Restoration Surgery. 19 (1): 27–29. doi:10.33589/19.1.0027. ISSN 2641-6719.
  2. 1 2 3 Sheppeard, Amanda (8 June 2022). "Meet the founding editor of Dermatology Republic". Dermatology Republic. Retrieved 5 April 2026.
  3. 1 2 3 "Rodney Sinclair". The Conversation. 16 February 2022. Retrieved 5 April 2026.
  4. 1 2 Wootton, Hannah (6 October 2022). "Hair loss: Australian researcher Rodney Sinclair's new treatment". Australian Financial Review. Retrieved 5 April 2026.
  5. ↑ Kolata G (August 18, 2022). "An Old Medicine Grows New Hair for Pennies a Day, Doctors Say". The New York Times. Archived from the original on August 19, 2022.
  6. ↑ Rodney Sinclair (16 May 2015). Female pattern hair loss: Combination therapy with low dose oral minoxidil and spironolactone. 2015 Annual Meeting of the Australasian Society for Dermatology Research.
  7. ↑ Rodney D. Sinclair (21 November 2015). Female Pattern Hair Loss: Combination Therapy With Low Dose Oral Minoxidil and Spironolactone (PDF). 9th World Congress for Hair Research, November 18-21, 2015, Miami, Florida, USA.
  8. ↑ Yang X, Thai KE (November 2016). "Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil". Australas J Dermatol. 57 (4): e130–e132. doi:10.1111/ajd.12350. PMID 25966934.
  9. ↑ Sinclair R (May 2016). "Treatment of monilethrix with oral minoxidil". JAAD Case Rep. 2 (3): 212–215. doi:10.1016/j.jdcr.2016.02.011. PMC 4887583. PMID 27284572.
  10. ↑ Dias FR, Yong SS, FitzGerald H, Sinclair RD, Bhoyrul B (2025). "Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations". Front Pharmacol. 16 1718208. doi:10.3389/fphar.2025.1718208. PMC 12898826. PMID 41695992.
  11. ↑ Debbarma, Salong (17 November 2025). "Samson Clinical concludes enrolment for Phase III AGA trial". Clinical Trials Arena. Retrieved 5 April 2026.
  12. ↑ "Sublingual minoxidil". AdisInsight. 24 November 2025. Retrieved 5 April 2026.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Rodney_Sinclair&oldid=1347456141"